N. Tamil Arasu Ph.D. Principal Scientist, Chemistry PTC Therapeutics April 28th, 2008
Biology
Assay development, protein expression and synthesis etc.
Pharmacology
Metabolism, PK studies, efficacy studies, animal model studies, enzyme inhibition studies etc.
Clinical Studies
Phase-1, 2 and 3 studies
Advantage India
Very cost effective Highly skilled English-speaking scientists are plenty Project Managers have experience from US and Europe Several well equipped companies are in the business IP protection strengthened after 2005
Research Alliance
FTE Model
FTE rates are fixed for specific term Some overhead cost is built within the FTE rate Most FTEs have a Masters Degree Some companies provide a full time Ph.D. manager without additional cost for every ~5 FTEs Most suitable for medicinal chemistry Flexibility in the projects
Summary
FTE model has been more beneficial to advanced discovery projects than early stage projects Outsourced R&D services to India significantly reduces the cost and time Long-term growth potential and sustainability unpredictable